Otc - Active Ingredient
platycodon root, licorice, jujube, peony root, ginger, poncirus immature fruit
Baenosin Capsule
FDA Label NDC 72988-0011
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Lydia Co., Ltd. for the product Baenosin (NDC 72988-0011). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, otc - purpose, otc - keep out of reach of children, indications & usage, warnings, dosage & administration, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Inactive Ingredient
lactose monohydrate, acacia, corn starch, carboxymethylcellulose calcium, l-menthol
Otc - Purpose
pyrogenic diseases with redness, swelling, stiffness and pain
Otc - Keep Out Of Reach Of Children
keep out of reach of the children
Indications & Usage
adults take 2 capsules 3 times a day before meals or between meals
Warnings
do not take this medicine if you have following symptoms
symptoms of headaches, chills, and fever other than local symptoms such as spasm (red with blood), swelling, and pain at the same time
Dosage & Administration
for oral use only
Package Label.Principal Display Panel
Label (Label)
* Please review the disclaimer below.
